drugset
drugset / Trial / NCT05200169

Mass Balance Recovery, Metabolite Profile and Metabolite Identification of 14C-AB1010 in Healthy Male Subjects

NCT05200169 ↗

Phase 0 Completed 4 enrolled AB Science
NaSingle-groupOpen-labelTreatment

Summary

To assess the mass balance recovery after a single oral dose of 14C-AB1010

Timeline

Start
2017-07-31
Primary completion
2017-09-01
Completion
2017-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Masitinib Small molecule 200 mg Oral

Indications

No indication recorded.